The technique of growing cells outside the human body itself is a significant advancement in scientific research. Cell culture technique has been around since mid-20th century and the field is continuously expanding into various areas of pharmaceutical research and development such as cancer and immunotherapy. Endeavor to improve the drug bioavailability and therapeutic efficacy has led to better research outcomes in cancer and health screening techniques. The ability to develop continuous cell lines has enabled mass production of desired organ cells for research and treatment benefits. Cell culture offers an excellent model system for studying the normal physiology and biochemistry, drug effects and drug screening. Being an exploratory research field, use of reagents, instruments and other consumables is very critical to support its advancements.

High Investment in research and development by biotechnological companies

Players in the global cell culture market are making major investments in R&D to introduce advanced products used in the cell culture process owing to rise in number of application and better return on investment. Furthermore, companies are inclined towards novel product development. For instance, Biovest International, in 2009, has developed a product named AutovaxID-C, which is expected to reshape the biologic production made in the industry. The product favors the automated cell growth by replacing conventional cell growth chambers that use to acquire a large space in the laboratory. Various other factors such as increasing prevalence of chronic diseases, high importance of tissue or organ replacement with cell culture process, and increasing demand for antibody production are in turn projected to fuel cell culture market growth. Also, rise in prevalence of age-related macular degeneration is expected to underpin the cell culture market growth. Eye conditions such as diabetic retinopathy in tune with rise in number of diabetic patients globally in turn creates a conducive environment for growth of the cell culture market. AMD ranks third with a prevalence of around 8.7% globally in 2015, according to W.H.O.

Market Dynamics

Increasing research on personalized therapies and stem cells is driving growth of the market for cell culture. Also, growing organ transplantation and biobanking of cells tissues and organs is driving growth of the market for cell culture instruments and consumables. According to the Global Observatory on Donation and Transplantation (GODT), around 119,873 organs were transplanted worldwide in 2014 (1.81% increase over 2013). The demand-supply gap of organ transplantation is a major problem faced globally. In the U.S. alone, nearly 118,652 patients are waiting for organ transplant (U.S. Department of Health & Human Service, 2017). Using cell culture technique to differentiate cells of liver, heart and nervous system would aid in the treatment of millions of such patients globally. Further, advent of 3D cell culture technique has enabled researchers to understand the body physiology and biological systems much better. Moreover, the spheroid formation and scaffold-based techniques are driving demand for 3D cell culture products.

Inquire Here Before Purchase of Research Report @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/116

Market Taxonomy

This report segments the global cell culture market on the basis of products, applications, end user, and geography. On the basis of product type, the market is segmented into consumables and instruments. The consumables market is categorized into media, sera, and reagents. The instruments market is categorized into culture systems, incubators, pipette, roller bottles, cryostorage equipment and biosafety cabinets. The end users segment comprises academic and research institutes and commercial pharma and biotech product manufacturers. For comprehensive understanding of market dynamics, the global cell culture market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., GE Healthcare, Corning, Inc., Sigma - Aldrich Corporation, VWR International, LLC, Merck KGAA, Becton, Dickinson and Company, Eppendorf AG, Sartorius AG and Lonza Group AG

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.


Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]